|Bid||7,645.00 x 0|
|Ask||7,645.00 x 0|
|Day's range||7,635.00 - 7,750.00|
|52-week range||71.46 - 10,120.00|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||35.18|
|Earnings date||29 Jul 2021|
|Forward dividend & yield||2.07 (2.70%)|
|Ex-dividend date||25 Feb 2021|
|1y target est||78.83|
Dr. Oni Blackstock, Health Justice Founder & Executive Director, joined Yahoo Finance to discuss the latest on covid-19.
Dr. Payal Patel, Infectious Diseases Physician, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus pandemic.
AstraZeneca (NASDAQ: AZN) at one time seemed to be in the driver's seat in the COVID-19 vaccine race. However, the big drugmaker has faced quite a few challenges in recent months, including a lawsuit filed by the European Union.